期刊文献+

高效液相色谱荧光检测法测定人血浆中帕珠沙星浓度 被引量:1

Determination of pazufloxacin in human plasma by RP-HPLC with fluorimetric detection
下载PDF
导出
摘要 目的:建立高效液相色谱法测定人血浆中帕珠沙星浓度。方法:色谱条件:Lichospher C18柱,以甲醇-0.5%三氟醋酸(40:60,v/v)为流动相,激发波长335nm,发射波长450nm。用10%高氯酸沉淀血浆蛋白,离心后取上清液进样。结果:血药浓度测定的线性范围为0.024~19.58mg·L^-1(r=0.9997)。最低检测限为30pg。绝对回收率在84.82%~92.69%.相对回收率在100.7%~104.8%。日内、日间RSD均小于10%。结论:本方法准确可靠、操作简便,适用于帕珠沙星药动学研究。 OBJECTIVE To establish a reverse phase HPLC method for the determination of pazufloxacin in human plasma. METHODS Plasma was deproteinized with 10% perchloric acid. After centrifugation, the supernatant was injected and eluted with methanol- 0. 5% trifluoroacetic acid (40:60,v/v) in a Lichospher C18 column. The wavelengths were 335(ex) and 450 nm (em), respectively. RESULTS The calibration curve was linear in human plasma within the range of 0. 024 - 19. 58 mg·L^-1 (r = 0. 999 7). The lowest limit of detection was 30 pg. The average recoveries of pazufloxacin were 100. 7 % - 104. 8%. The RSD of the within-day and between-day were all lower than 10%. CONCLUSION The present study provides a simple and reliable quantitative method for the pharmacokinetic study of pazufloxacin.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2006年第9期1104-1106,共3页 Chinese Journal of Hospital Pharmacy
关键词 帕珠沙星 反相高效液相法 荧光检测法 血药浓度 pazufloxacin RP-HPLC fluorimitric detection plasma concentration
  • 相关文献

参考文献5

二级参考文献8

  • 1Nakashima M Uemura K Kosuge K et al.Phase Ⅰ clinical study of pazufloxacin mesilate [J].Japan J Chemother,1999,47(1):141-141.
  • 2Hayakawa H ,Fujimaki K,Shimizu Y,et al. Metabolic fate of pazufloxacin mesilate in human and animals. Japan J Chemother, 1999,47( Suppl 1 ) :81.
  • 3Mitsuyama J, Miyazaki S, Ishii Y, et al. Antibacterial activity of a new injectable quinolone pazufloxacin mesylate in vitro and in vivo[J]. Jpn J Chemother, 1999;47(Suppl.1):S1-S15.
  • 4Nishino T, Ikeda Y, Otsuki M, et al. In vitro and in vivo antibacterial activity of pazufloxacin mesylate, a new parenteral fluoroquinolone[J]. Jpn J Chemother, 1999;47(Suppl.1):S25-S36.
  • 5Mikamo H, Sato Y, Hayasaki Y, et al. In vitro activities of pazufloxacin, an injectable new quinolone, against bacteria causing infections in obstertric and gynecological patients [J]. Jpn J Chemother, 1999;47(Suppl. 1):S 16-S38.
  • 6Mitsuyama J, Takahata M, Yamashiro Y, et al. Antibacterial activity of a new injectable quinolone, pazufloxacin mesylate, in vitro and in vivo [J]. Jpn J Chemother, 1999;47(Suppl. 1):S37-S64.
  • 7胡欣,闫小燕,曹国颖,何笑荣.RP-HPLC法测定甲磺酸帕珠沙星及有关物质[J].中国新药杂志,2002,11(11):862-865. 被引量:23
  • 8杨信怡,游雪甫.注射用帕珠沙星的药理研究和临床应用[J].国外医药(抗生素分册),2003,24(2):80-87. 被引量:59

共引文献76

同被引文献2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部